Nme8 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
[^1]
[^2]
[^3]
[^4]
| Gene Symbol | NME8 |
|---|
| Full Name | NME/NDP Kinase 8 (Thioredoxin Domain Containing) |
|---|
| Chromosomal Location | 7p14.3 |
|---|
| NCBI Gene ID | 29803 |
|---|
| OMIM | 607420 |
|---|
| Ensembl ID | ENSG00000186919 |
|---|
| UniProt ID | Q9NPJ3 |
|---|
| Associated Diseases | Retinitis Pigmentosa, Spinocerebellar Ataxia, Alzheimer's Disease |
|---|
NME8 encodes a protein with nucleoside diphosphate kinase (NDPK) activity and a thioredoxin domain. Also known as TXNDC3, this protein is involved in sperm motility, ciliary function, and has been implicated in neurodegenerative diseases.
NME8 contains:
- NDPK Domain: Nucleoside diphosphate kinase activity
- Thioredoxin Domain: Oxidoreductase activity
- Ciliary/Flagellar Function: Essential for sperm motility and respiratory cilia
- NDPK Activity: Maintains nucleotide pools for DNA/RNA synthesis
- Thioredoxin Activity: Antioxidant function, maintaining cellular redox balance
- Microtubule Regulation: Involved in microtubule organization
- Protein Thiol-Disulfide Oxidoreductase: Catalyzes disulfide bond formation/reduction
- NME8 mutations cause Leber congenital amaurosis and retinitis pigmentosa
- Photoreceptor outer segment function requires proper ciliary structure
- Loss of NME8 leads to photoreceptor degeneration
- Rare NME8 variants associated with SCA
- Cerebellar dysfunction due to ciliary defects in Purkinje cells
- Axonal transport impairments
- NME8 expression reduced in AD brain
- Possible role in microtubule function and tau phosphorylation
- Redox imbalance may contribute to neurodegeneration
- Some association with PD risk in GWAS studies
- May affect mitochondrial function
- Possible role in neuronal survival
NME8 is expressed in:
- Testis (highest)
- Retina
- Brain (cerebellum, cortex)
- Respiratory epithelium
- Oviduct
In brain:
- Cerebellar Purkinje cells
- Hippocampal neurons
- Retinal photoreceptors
- Gene Therapy: AAV delivery for retinal degeneration
- Antioxidant Strategies: Targeting redox pathways
- Microtubule Stabilizers: Similar to taxanes
- NDPK Modulators: Affecting nucleotide metabolism
- Understanding NME8 function in neurons
- Therapeutic approaches for retinal degeneration
- Link between ciliary dysfunction and neurodegeneration
- NME8 knockout mice show male infertility
- Zebrafish models show ciliary defects
- Mouse models of retinal degeneration developed
The study of Nme8 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
NME8 shows specific expression patterns:
- Brain regions: Retina, olfactory epithelium, testis, and respiratory epithelium
- Cell types: Photoreceptor cells, olfactory sensory neurons, and respiratory ciliated cells
- Subcellular localization: Cytoplasmic with mitochondrial association
In the brain, NME8 expression is highest in the retina and olfactory bulb, consistent with its role in ciliary function.
NME8/TXNDC3 contains multiple functional domains:
Key- **S-- *
NME8-based therapies are being explored:
- Redox Modulation: NME8 activators for oxidative stress in neurodegeneration
- Gene Therapy: AAV-mediated NME8 delivery for retinal degeneration
- Small Molecule Approaches: Enhancing NDPK activity
Potential applications:
- Retinitis pigmentosa treatment
- Neuroprotection in AD/PD through antioxidant effects
- Ciliary function restoration
- Nme8 knockout mice: Show retinal degeneration and male infertility
- Zebrafish models: Nme8 knockdown causes photoreceptor loss
- C. elegans: Homolog (nme-2) knockdown affects sensory functions
- Understanding NME8's role in retina degeneration
- Developing NME8-based antioxidant therapies
- Biomarker development: NME8 levels in neurodegenerative disease
- Gene therapy vectors for NME8 delivery